Corcept Therapeutics, Inc. (CORT)
112.79
-2.13
(-1.85%)
USD |
NASDAQ |
Sep 11, 16:00
111.13
-1.66
(-1.47%)
After-Hours: 04:15
Corcept Therapeutics Price to Book Value : 17.25 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 17.25 |
| September 10, 2026 | 17.57 |
| September 09, 2026 | 17.69 |
| September 08, 2026 | 17.43 |
| September 04, 2026 | 17.07 |
| September 03, 2026 | 17.25 |
| September 02, 2026 | 16.89 |
| September 01, 2026 | 17.34 |
| August 31, 2026 | 17.33 |
| August 28, 2026 | 17.41 |
| August 27, 2026 | 17.88 |
| August 26, 2026 | 18.32 |
| August 25, 2026 | 18.90 |
| August 24, 2026 | 18.84 |
| August 21, 2026 | 18.69 |
| August 20, 2026 | 18.51 |
| August 19, 2026 | 18.20 |
| August 18, 2026 | 18.06 |
| August 17, 2026 | 17.92 |
| August 14, 2026 | 17.50 |
| August 13, 2026 | 16.90 |
| August 12, 2026 | 17.15 |
| August 11, 2026 | 17.10 |
| August 10, 2026 | 17.47 |
| August 07, 2026 | 16.94 |
| Date | Value |
|---|---|
| August 06, 2026 | 16.51 |
| August 05, 2026 | 16.93 |
| August 04, 2026 | 16.79 |
| August 03, 2026 | 17.25 |
| July 31, 2026 | 17.51 |
| July 30, 2026 | 18.09 |
| July 29, 2026 | 14.21 |
| July 28, 2026 | 14.40 |
| July 27, 2026 | 13.93 |
| July 24, 2026 | 14.58 |
| July 23, 2026 | 14.78 |
| July 22, 2026 | 13.90 |
| July 21, 2026 | 14.63 |
| July 20, 2026 | 14.00 |
| July 17, 2026 | 13.84 |
| July 16, 2026 | 13.72 |
| July 15, 2026 | 13.70 |
| July 14, 2026 | 13.83 |
| July 13, 2026 | 13.14 |
| July 10, 2026 | 14.05 |
| July 09, 2026 | 14.26 |
| July 08, 2026 | 14.21 |
| July 07, 2026 | 14.38 |
| July 06, 2026 | 14.01 |
| July 02, 2026 | 13.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.01 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 7.541 |
| Liquidia Corp. | 30.48 |
| Merck & Co., Inc. | 8.473 |
| Pfizer Inc. | 1.854 |
Price to Book Value Related Metrics
| PE Ratio | 269.38 |
| PS Ratio | 15.68 |
| Price to Free Cash Flow | 121.87 |
| Price | 112.79 |
| Earnings Yield | 0.37% |
| Market Cap | 12.17B |
| Operating PE Ratio | 2034.42 |
| Normalized PE Ratio | 269.38 |